Treatment of heart failure and ascites with ultrafiltration in patients with intractable alcoholic cardiomyopathy

Panminerva Medica

Volumn 44, Issue 1, 2002, Pages 23-25

  Bilora, F ^a,b   Petrobelli, F ^a   Boccioletti, V ^a   Pomerri, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Ascites, therapy; Cardiomyopathy, alcoholic, therapy; Heart failure, congestive, therapy; Peritoneal dialysis

Indexed keywords

AGED; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; ASCITES; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS;

AGED; ASCITES; CARDIOMYOPATHY, ALCOHOLIC; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 0036516057     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rubin E. Alcoholic myopathy in heart and skeletal muselc. N Engl J Med 1979;301:128-32.
2. Braunwald E. Trattato di medicina cardiovascolare. Padova: Ed. Piccin Nuova Libreria, 1989.
3. Bing RI. Cardiac metabolism: its contribution to alcoholic heart desease and myocardial failure. Circulation 1978;58:965-71.
4. Lange LG, Sobel BE. Impaired cardiac mitochondrial function induced by specific metabolites of ethanol: fatty acid and ethyl esters. J Am Coll Cardiol 1983;667:443-7.
5. Regan TI, Lesinson GE, Oldwurtel HA, Ettinger PO, Lyons MM, Haider B et al. Ventricular function in non cardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopaty. J Clin Invest 1969;8:397-402.
6. Friedman HS, Lieber CS. Cardiotoxicity of alcohol. Cardiovasc Med 1977;2:111-7.
7. Regan TL, Haider B, Ahmed SS, Oldwurtel H, Ettinger PO, Lyons MM. Whiskey and the heart. Cardiovasc Med 1977;2:165-70.
8. Regan TJ, Ettinger PO, Lyons MM, Ahmed SS, Levinson GE, Oldwurtel H. Ethyl alcohol as a cardiac risk factor. Curr Probl Cardiol 1977;2:1-9.
9. Bridgen W. Alcoholic: cardiomyopathy. In: Burck GE, editor. Cardiomyopaty (Cardiovascular Clinics Series). Philadelphia: F. A. Davis Co, 1972:188.
10. Burch GE, De Pasquale NP. Alcoholic cardiomyopathy. Am J Cardiol 1969;23:723-7.
11. Mathews EC, Gardin JM, Henry WL. Echocardiographics abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 1981;47:570-6.
12. Demakis JG, Proskey A, Rahinitoola SH. The natural course of alcoholic cardiomyopathy. Ann Intern Med 1974;80:293-301.
13. Morgan SH, Mansell MA, Thomson FD. Fluid removal by hemofiltration in diuretic resistant cardiac failure. Br Heart 1985;54:218-22.
14. Tormey V, Conlon PJ, Farrel J. Long term successful management of refractory congestive cardiac failure by intermittent ambulatory pentoneal ultrafiltration. QJM 1996;89:681-9.
15. Marenzi G, Grazzi S, Giraldi F, Della Bella P. Interrelation of humoral factors, hemodynamics and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993;94:49-53.
16. Ho KK, Anderson KM, Kannel WB, Grossnian W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-13.
17. Ryckelynck LP, Lobbedez T, Valette B, Le Goffic C, Mazouz O, Levaltier B et al. Peritoneal ultrafiltration and tretment-resistant heart failure. Nephrol Dial Trasplant 1998;13(Suppl 4):56-61.
18. Dranitzki ME, Rubinger D, Moscovici A, Haviv YS, Friedlander MM, Silver J et al. CAPD to improve quality of life patients with refractory heart failure. Nephrol Dial Transplant 1998;13:3041-9.
19. Canaud BJ, Leblanc M, Leray Moragues H, Delmas S, Klouche K et al. Slow continuos and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 1998:13(Suppl 4):51-8.
20. Mc Goven PG, Pankow JS, Shahar E, Doliszky KM, Folsorm AR, Blackburn H et al. Recent trends in acute coronary heart disease. Mortality, morbility, medical care, risk factors. N Engl J Med 1996;285:144-7.
21. Kornowski R, Zeeli D, Averbuch M, Finkelstein A, Schwarz D, Moshkovitz M et al. Intensive home care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-7.